CYTOF
PINK Altamira Therapeutics Ltd.$0.0900 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0900, and at the day’s high of $0.0900
- YTD change
- -2.69%
- vs 20-day SMA
- +27.00%
- vs 200-day SMA
- +11.76%
Price ranges
Price & Performance
+0.03 (+50.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 55.0% away from all-time highs of $0.2000
- CYTOF is down 3% since the beginning of the year
- CYTOF is up 12% over the past 12 months
- CYTOF is up 29% over the past 1 month
- 0% of all CYTOF investors are betting against CYTOF
CYTOF reads n/a: price sits above both the 20- and 200-day averages, the 12-month move is +12.5%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0015
- Last 5 days
- +1.69%
- vs 8-day SMA
- +21.70%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.